Studies have shown that altering the activity or the expression level of STK25 and regulating cell proliferation/apoptosis/polarity by STK25/GM130/PDCD10 may provide new directions for tumor therapy [43–46]. This evidence concerns the gene PDCD10 and neoplasm.